Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach

Bone Marrow Transplantation volume 46, pages 330–337 (2011)Cite this article

Subjects

Abstract

Allogeneic hematopoietic SCT (HSCT) has been proposed as a treatment for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). HSCT has been performed in nine patients using different protocols with varying success. Based on this preliminary experience, participants of the first consensus conference propose a common approach to allogeneic HSCT in MNGIE. Standardization of the transplant protocol and the clinical and biochemical assessments will allow evaluation of the safety and efficacy of HSCT as well as optimization of therapy for patients with MNGIE.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Nishino I, Spinazzola A, Hirano M . Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689–692.

    Article  CAS  PubMed  Google Scholar 

  2. Hirano M, Nishigaki Y, Martí R . Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 2004; 10: 8–17.

    Article  PubMed  Google Scholar 

  3. Martí R, Verschuuren JJ, Buchman A, Hirano I, Tadesse S, van Kuilenburg AB et al. Late-onset MNGIE due to partial loss of thymidine phosphorylase activity. Ann Neurol 2005; 58: 649–652.

    Article  PubMed  Google Scholar 

  4. Bardosi A, Creutzfeldt W, DiMauro S, Felgenhauer K, Friede RL, Goebel HH et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol 1987; 74: 248–258.

    Article  CAS  PubMed  Google Scholar 

  5. Needham M, Duley J, Hammond S, Herkes GK, Hirano M, Sue CM . Mitochondrial disease mimicking Charcot-Marie Tooth disease. J Neurol Neurosurg Psychiatry 2007; 78: 99–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Carod-Artal FJ, Herrero MD, Lara MC, López-Gallardo E, Ruiz-Pesini E, Martí R et al. Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation. Eur J Neurol 2007; 14: 581–585.

    Article  CAS  PubMed  Google Scholar 

  7. Martín MA, Blázquez A, Martí R, Bautista J, Lara MC, Cabello A et al. Lack of gastrointestinal symptoms in a 60-year-old patient with MNGIE. Neurology 2004; 63: 1536–1537.

    Article  PubMed  Google Scholar 

  8. López LC, Akman HO, García-Cazorla A, Dorado B, Martí R, Nishino I et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet 2009; 18: 714–722.

    Article  PubMed  Google Scholar 

  9. Hirano M, Lagier-Tourenne C, Valentino ML, Martí R, Nishigaki Y . Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 2005; 354: 152–156.

    Article  CAS  PubMed  Google Scholar 

  10. Pontarin G, Ferraro P, Valentino ML, Hirano M, Reichard P, Bianchi V . Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 2006; 28: 22720–22728.

    Article  Google Scholar 

  11. Peters C . Hematopoietic cell transplantation for storage diseases. In: Appelbaum FR, Forman SJ, Negrin RS, Blume K (eds). Thomas’ Hematopoietic Cell Transplantation, 4th edn. Wiley-Blackwell Publishing Ltd: Chichester, West Sussex, UK, 2009, pp 1136–1162.

    Chapter  Google Scholar 

  12. Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002; 277: 4128–4133.

    Article  CAS  PubMed  Google Scholar 

  13. Yavuz H, Ozel A, Christensen M, Christensen E, Schwartz M, Elmaci M et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007; 64: 435–438.

    Article  PubMed  Google Scholar 

  14. Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006; 67: 1461–1463.

    Article  CAS  PubMed  Google Scholar 

  15. Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006; 67: 1458–1460.

    Article  CAS  PubMed  Google Scholar 

  16. Hirano M, Casali C, Tadesse S et al. Sustained biochemical and clinical improvements two years postallogeneic stem cell transplantation in a patient with MNGIE. AAN Annual Meeting 2008 (Abstract S48.002, April 2008. Available from www.abstracts2view.com/aan2008chicago/ (accessed on 13 April 2010)).

  17. Illa Sendra I, Lara Castillo MC, Valcarel Ferreiras D, Nogues Galvez N, Dias Manera J, Rojas-Garcia R et al. Transplante alogénico de células madre hematopoyéticas en dos pacientes con MNGIE. Neurologia 2008; 23: 682.

    Google Scholar 

  18. Hill KS, Richardson D, Hammans S, Stroud M, Fine D, Walker V et al. Successful allogeneic peripheral blood stem cell transplantation from an HLA-identical sibling in a patient with mitochondrial neurogastrointestinal encephalomyelopathy. Bone Marrow Transpl 2009; 43 (Suppl 1): S184 (abstract).

    Google Scholar 

  19. Halter J, Schuepbach WMM, Casali C, Elhasid R, Fay K, Hammans S et al. Sustained complete metabolic remission after allogeneic hematopoietic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Blood (ASH Annual Meeting Abstracts) 2009; 114: abstract 1181.

  20. Martí R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M . Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays. Clin Chem 2004; 50: 120–124.

    Article  PubMed  Google Scholar 

  21. Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 2007; 25: 4246–4254.

    Article  PubMed  Google Scholar 

  22. Parimon T, Au DH, Martin PJ, Chien JW . A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 2006; 144: 407–414.

    Article  PubMed  Google Scholar 

  23. Lara MC, Valentino ML, Torres-Torronteras J, Hirano M, Martí R . Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches. Biosci Rep 2007; 27: 151–163.

    Article  CAS  PubMed  Google Scholar 

  24. Niederwieser D, Pepe M, Storb R, Loughran Jr TP, Longton G . Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia. Br J Haematol 1988; 69: 23–28.

    Article  CAS  PubMed  Google Scholar 

  25. Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD et al. International Bone Marrow Transplant Registry; European Group for Blood and Marrow Transplantation. Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108: 4288–4290.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sudharsan PT, Mythili Y, Selvakumar E, Varalakshmi P . Lupeol and its ester exhibit protective role against cyclophosphamide-induced cardiac mitochondrial toxicity. J Cardiovasc Pharmacol 2006; 47: 205–210.

    Article  CAS  PubMed  Google Scholar 

  27. Ogawa Y, Nishioka A, Kobayashi T, Kariya S, Hamasato S, Saibara T et al. Mitochondrial cytochrome c release in radiation-induced apoptosis of human peripheral T cells. Int J Mol Med 2002; 10: 263–268.

    CAS  PubMed  Google Scholar 

  28. Chung HC, Kim SH, Lee MG, Cho CK, Kim TH, Lee DH et al. Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2E1 (CYP2E1) in rat liver. Toxicology 2001; 161: 79–91.

    Article  CAS  PubMed  Google Scholar 

  29. Miller JH, Jin S, Morgan WF, Yang A, Wan Y, Aypar U et al. Profiling mitochondrial proteins in radiation-induced genome-unstable cell lines with persistent oxidative stress by mass spectrometry. Radiat Res 2008; 169: 700–706.

    Article  CAS  PubMed  Google Scholar 

  30. De Weerdt A, Claeys KG, De Jonghe P, Ysebaert D, Chapelle T, Roeyen G et al. Tacrolimus-related polyneuropathy: case report and review of the literature. Clin Neurol Neurosurg 2008; 110: 291–294.

    Article  PubMed  Google Scholar 

  31. Muñoz R, Espinoza M, Espinoza O, Andrade A, Bravo E, González F . Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases. Transplant Proc 2006; 38: 921–923.

    Article  PubMed  Google Scholar 

  32. Soriano ME, Nicolosi L, Bernardi P . Desensitization of the permeability transition pore by cyclosporin A prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha. J Biol Chem 2004; 279: 36803–36808.

    Article  CAS  PubMed  Google Scholar 

  33. Rodríguez LC, Araujo CR, Posleman SE, Rey Mdel R . Hepatotoxic effect of cyclosporin A in the mitochondrial respiratory chain. J Appl Toxicol 2007; 27: 310–317.

    Article  PubMed  Google Scholar 

  34. Almeida S, Domingues A, Rodrigues L, Oliveira CR, Rego AC . FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. Neurobiol Dis 2004; 17: 435–444.

    Article  CAS  PubMed  Google Scholar 

  35. Han SY, Chang EJ, Choi HJ, Kwak CS, Suh SI, Bae JH et al. Effect of tacrolimus on the production of oxygen free radicals in hepatic mitochondria. Transplant Proc 2006; 38: 2242–2243.

    Article  CAS  PubMed  Google Scholar 

  36. Choi SJ, You HS, Chung SY . Rapamycin-induced cytotoxic signal transduction pathway. Transplant Proc 2008; 40: 2737–2739.

    Article  CAS  PubMed  Google Scholar 

  37. Chen C, Liu Y, Liu R, Ikenoue T, Guan KL, Liu Y et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008; 205: 2397–2408.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Storb R, Deeg HJ, Pepe M, Appelbaum F, Anasetti C, Beatty P et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial. Blood 1989; 73: 1729–1734.

    CAS  PubMed  Google Scholar 

  39. Santos NA, Medina WS, Martins NM, Mingatto FE, Curti C, Santos AC . Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 2008; 22: 1143–1152.

    Article  CAS  PubMed  Google Scholar 

  40. Chiyonobu T, Noda R, Yoshida M, Fujiki A, Ishii R, Nukina S et al. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev 2008; 30: 430–433.

    Article  PubMed  Google Scholar 

  41. Omar RF, Harvie P, Gourde P, Désormeaux A, Tremblay M, Beauchamp D et al. Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model. Toxicol Appl Pharmacol 1997; 143: 140–151.

    Article  CAS  PubMed  Google Scholar 

  42. Hanes JW, Zhu Y, Parris DS, Johnson KA . Enzymatic therapeutic index of acyclovir. Viral versus human polymerise gamma specificity. J Biol Chem 2007; 282: 25159–25167.

    Article  CAS  PubMed  Google Scholar 

  43. Rodriquez RJ, Acosta Jr D . Inhibition of mitochondrial function in isolated rate liver mitochondria by azole antifungals. J Biochem Toxicol 1996; 11: 127–131.

    Article  Google Scholar 

  44. Guillaume MP, De Prez C, Cogan E . Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolonged fluconazole administration. Am J Gastroenterol 1996; 91: 165–168.

    CAS  PubMed  Google Scholar 

  45. Palenzuela L, Hahn NM, Nelson Jr RP, Arno JN, Schobert C, Bethel R et al. Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin Infect Dis 2005; 40: e113–e116.

    Article  PubMed  Google Scholar 

  46. Nagiec EE, Wu L, Swaney SM, Chosay JG, Ross DE, Brieland JK et al. Oxazolidinones inhibit cellular proliferation via inhibition of mitochondrial protein synthesis. Antimicrob Agents Chemother 2005; 49: 3896–3902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Leton III LJ . Assessement of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456–1479.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

RM is supported by a grant from Instituto de Salud Carlos III (PI06/0735). MH is supported by US National Institutes of Health (NIH) Grants HD32062 and RCNS070232 by grants from the Muscular Dystrophy Association, and by the Marriott Mitochondrial Disorders Clinical Research Fund (MMDCRF). The consensus conference was supported by a travel grant from Swiss Blood Stem Cells and a grant from the Swiss Foundation for Research on Muscle Diseases.

Author information

Author notes

  1. J Halter and W M M Schüpbach: These authors contributed equally to this work.

  2. A Gratwohl and M Hirano: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Hematology, University Hospital Basel, Basel, Switzerland

    J Halter, T Lehmann & A Gratwohl

  2. Centre d’Investigation Clinique, Fédération des Maladies du Système Nerveux & INSERM UMR 679, Pitié-Salpxêtrière Group, Paris, France

    W M M Schüpbach & H Mattle

  3. Department of Neurology, University Hospital-Inselspital Bern, Bern, Switzerland

    W M M Schüpbach, L Kappeler & H Mattle

  4. Neurology, La Sapienza University, University Hospital, Rome, Italy

    C Casali

  5. Pediatric-Oncology, Rambam Medical Centre, Haifa, Israel

    R Elhasid

  6. Department of Hematology, St Vincent's Hospital, Darlinghurst, Sydney, Australia,

    K Fay

  7. Wessex Neurological Centre, Southampton University Hospital Trust, Southampton, UK

    S Hammans

  8. Neurology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain

    I Illa

  9. Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland

    S Krähenbühl

  10. Pediatrics, Rambam Medical Centre, Haifa, Israel

    H Mandel

  11. Institut de Recerca, University Hospital Vall d’Hebron and CIBERER, Barcelona, Spain

    R Marti

  12. Department of Haematology, University of Southampton, Southampton, UK

    K Orchard

  13. Department of Haematology, Columbia University Medical Centre, New York, NY, USA

    D Savage

  14. Department of Neurogenetics, University of Sydney Kolling Institute for Medical Research, Kolling Institute for Medical Research, Royal North Shore Hospital and University of Sydney, Sydney, Australia

    C M Sue

  15. Department of Hematology, Santa Creu i San Pau Hospital, Barcelona, Spain

    D Valcarcel

  16. Department of Neurology, Columbia University Medical Centre, New York, NY, USA

    M Hirano

Authors
  1. J Halter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W M M Schüpbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C Casali
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Elhasid
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Fay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Hammans
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I Illa
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L Kappeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Krähenbühl
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. T Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H Mandel
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R Marti
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. H Mattle
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. K Orchard
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. D Savage
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. C M Sue
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. D Valcarcel
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. A Gratwohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. M Hirano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Halter.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halter, J., Schüpbach, W., Casali, C. et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46, 330–337 (2011). https://doi.org/10.1038/bmt.2010.100

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.100

Keywords

This article is cited by

Search

Advanced search

Quick links